Daniel De Armond, MD
Dr. Daniel De Armond is a thoracic surgeon who specializes in minimally invasive thoracic surgery for the treatment of lung cancer. He is the Chief of the Division of Thoracic Surgery within the Department of Cardiothoracic Surgery at UT Health San Antonio.
Dr. De Armond has significant expertise in video-assisted thoracoscopic (VATS) and robotic-assisted pulmonary, esophageal, and mediastinal surgery with an emphasis on VATS lobectomy for the treatment of lung cancer. He also manages all facets of lung transplantation services, from donor management and donor/recipient selection to preoperative workup, surgery, and post-operative care.[1]
Education and Career
For his undergraduate studies, Dr. De Armond attended the University of California in Los Angeles, where he earned a bachelor of arts degree in French. He earned his medical degree at the Medical College of Pennsylvania in Philadelphia, Pennsylvania, then completed an internship and residency in Surgery at the University of Texas Health Science Center at San Antonio, where he was later named Senior Resident of Surgery and Chief Resident of Surgery. Dr. De Armond then pursued a postdoctoral fellowship in Cardiothoracic Surgery at the University of Iowa Hospitals and Clinic, and a clinical fellowship in Minimally Invasive Thoracic Surgery at Cedars-Sinai Medical Center.[1]
His appointments include having been a staff physician and Director of Minimall Invasive Lung Surgery at the University of Texas Health Science Center at San Antonio, Medical Director of the South Texas Lung Institute at St. Luke’s Baptist Hospital, and Associate Professor and Clinical and Chief of the Division of General Thoracic Surgery.
Research
Dr. De Armond’s research is focused on molecular mechanisms of lung cancer, mechanisms and diagnosis of rejection in lung transplantation, and the development of novel medical devices and drug therapies related to thoracic surgery.
His recent publications include:[1]
- Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer. Taverna JA, Hung CN, DeArmond DT, Chen M, Lin CL, Osmulski PA, Gaczynska ME, Wang CM, Lucio ND, Chou CW, Chen CL, Nazarullah A, Lampkin SR, Qiu L, Bearss DJ, Warner S, Whatcott CJ, Mouritsen L, Wade M, Weitman S, Mesa RA, Kirma NB, Chao WT, Huang TH. Cancer Res. 2020 Apr 1;80(7):1551-1563. doi: 10.1158/0008-5472.CAN-19-3183. Epub 2020 Jan 28. PMID: 31992541 Free PMC article.
- Intrapleural Impedance Sensor Real-Time Tracking of Pneumothorax in a Porcine Model of Air Leak. DeArmond DT, Das NA, Restrepo CS, Katona MA, Johnson SB, Hernandez BS, Michalek JE. Semin Thorac Cardiovasc Surg. 2020 Summer;32(2):357-366. doi: 10.1053/j.semtcvs.2019.10.004. Epub 2019 Oct 11. PMID: 31610232
- Pleural electrical impedance is a sensitive, real-time indicator of pneumothorax. DeArmond DT, Das NA, Restrepo CS, Johnson SB, Michalek JE, Hernandez BS. J Surg Res. 2018 Nov;231:15-23. doi: 10.1016/j.jss.2018.05.005. Epub 2018 May 30. PMID: 30278922
- The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model. Das NA, Peters JI, Simmons JD, Wang Y, O’Donnell KP, DeArmond DT, Coalson JJ, Brooks EG, Johnson SB. J Thorac Cardiovasc Surg. 2017 Dec;154(6):2144-2151.e1. doi 10.1016/j.jtcvs.2017.07.083. Epub 2017 Sep 1. PMID: 28942970 Free article.
- Online learning in thoracic surgical training: promising results of multi-institutional pilot study. Antonoff MB, Verrier ED, Yang SC, Lin J, DeArmond DT, Allen MS, Varghese TK Jr, Sengewald D, Vaporciyan AA. Ann Thorac Surg. 2014 Sep;98(3):1057-63. doi: 10.1016/j.athoracsur.2014.04.062. Epub 2014 Jul 29. PMID: 25085560
